Highlights from Supply Side West 2023: Unveiling MenaQ7® Protect

Share this article:

Highlights from Supply Side West 2023 Unveiling MenaQ7® Protect
This year’s SupplySide West set the stage for our first-of-its-kind, ready-to-market K2 finished product: MenaQ7® Protect, on-the-go immune support for the active lifestyler. 

A Step Change in the MenaQ7® Portfolio

Amidst the hustle and bustle of SupplySide West, the Gnosis team was excited to unveil our latest portfolio development – a turnkey immune product designed to bolster one’s foundational health, in a dose form that is meant to seamlessly support the fast-moving, quality-driven consumer. The product is a result of the successful partnership between Gnosis and Probiotcal. 

This launch marks a significant milestone in the MenaQ7® journey: introducing a ready-to-market private label finished product. This step change presents brand owners with clear advantages, enabling them to bypass the often-time-consuming development phase and proceed directly to product launch. They can do so with the assurance that they are offering a science backed, branded ingredient in a well-formulated supplement, perfectly positioned for a targeted audience. The launch is a true testament to one of our guiding pillars: Come for K2 Science, Stay for the Partnership. 

Gnosis Cocktail Party: A Chance to Re-Connect and Re-Explore

An event like SupplySide West is a whirlwind of meetings, impressions, and long hours walking the show floor. That is why gathering with industry friends at the Gnosis Cocktail party was a welcomed treat to connect over refreshments before kicking off the big show. The event set a nice frame for the introduction of MenaQ7® Protect and allowed for brands to have more informal discussions with members from both the Gnosis and Probiotcal teams on how individual brands can leverage this new offering with their consumer base, who like our industry, are constantly exploring how best to support their overall health and wellbeing.  A key K2 takeaway from the show is the high-level engagement from the audience and the keen interest that comes with the ever-evolving MenaQ7® Portfolio, now uniting the clinically proven MenaQ7® K2 with vitamin C and three unique probiotic strains for an innovative foundational and immunesupporting supplement. 

101 rue de Menin
59700 Marcq-en-Baroeul

Subscribe to our newsletter

The latest news, articles, and resources, sent to your inbox twice a month.

The information provided here is, to the best of our knowledge, true and accurate. However, our products must only be used in compliance with local laws and regulations. We cannot guarantee the freedom of use for every intended application or country. These statements may not have been evaluated by your local Food and Drug Administration. Our products are not intended to diagnose, treat, cure, or prevent any disease. A healthy, balanced and diversified diet should fulfill all nutritional needs.